New Insights From An Old Drug: Carbenoxolone, Huntington’s Disease And Alcoholism
This article was originally published in Start Up
Executive Summary
The old and little used gastritis and ulcer drug carbenoxolone is now being developed as a Huntington’s disease treatment. New research also hints at a role for it in treating alcohol abuse.
You may also be interested in...
Understanding How To Develop BTK Inhibitors In MS Is Evolving
Having a reversible BTK inhibitor in the multiple sclerosis armamentarium could be the best way to favorably impact the treatment landscape.
Science Matters: Setting The Stage For Using Wearables In Oncology Drug Development
Digital biomarkers using data collected with wearable devices are making their way into clinical trials, largely in cardiovascular, respiratory and rare disease settings around physical activity metrics.
Science Matters: Setting The Stage For Using Wearables In Oncology Drug Development
Digital biomarkers using data collected with wearable devices are making their way into clinical trials, largely in cardiovascular, respiratory and rare disease settings around physical activity metrics.